Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
1. Mr. Goh apologised to the shareholders regarding the wrong investment decision with the Edenor. At first, it's thought a great deal as the business partners were experienced and capable of turning around the oleochemical plants previously.…
Short term pain , but good in long term. Carrying value of the joint ventures was around 100m, means we should see impairment loss on joint ventures in this year. Long term wise there’s no need to further pump in cash as well as recognise the losses anymore.
Another thing is management choose to file the application right before AGM which happens tomorrow hmm guess they want transparency. But weird thing is share price have good support recently.
Key Takeaways:
1. Edenor's breakeven level or profitable requiring the capacity utilisation for 80-95%. Now its capacity utilisation is 62%. The competition has been too fierce, now facing the overcapacity and the policy of the Indonesia. This year's target is to reduce/control the losses.
@edison u r very greedy, u r expecting every stock also have dy 6% above like maybank so that u can buy everything, now the issue is maybank will no more increase dividend yield, but this stock keep increasing the dividend yield every half year, i would suggest u wait until this stock increase dy to 6%, but i m sure tat time the price is not the price anymore
@edison now most of the stock in bursa have dividend yield less than 3%, u can wish that all these stock price chop to half now so that u can buy cheap, wish ur dream come true
edenor is the known issue and previous net profit already count it in, and now edenor loss reduced quarter by quarter, for the forex, usd dropped from 4.4 - 4 (roughly 10%), but mfcb price dropped far more than 10% since early 2025, it is already undervalue price